AASLD publishes first expert practice opinion guidance; EASL updates hepatitis B eligibility

Two major liver disease clinical guidance updates have been filed publicly as of 15 October 2026.

Stands on 3 placed sources from 2 publishers.

New liver disease guidelines published by major medical groups AI illustrationhow this picture was made

On 15 October 2026, the American Association for the Study of Liver Diseases announced publication of its first ever Expert-Based Practice Opinion clinical guidance document.^[1] The 2025 European Association for the Study of the Liver Clinical Practice Guidelines expanded hepatitis B treatment eligibility. The guidelines do not recommend treatment for all HBV DNA-positive individuals.^[2] Current treatment guidelines from both the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver are mainly based on serum HBV DNA, alanine aminotransferase levels, and liver histology.^[3]

Proof3 sources · 2 publishers · signed

What this stands on

On 2026-10-15, the American Association for the Study of Liver Diseases announced publication of its first ever Expert-Based Practice Opinion clinical guidance document. · AASLD
The 2025 European Association for the Study of the Liver Clinical Practice Guidelines expanded hepatitis B treatment eligibility but do not recommend treatment for all HBV DNA-positive individuals. · bmj.com
Current treatment guidelines from the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL) are mainly based on serum HBV DNA, alanine aminotransferase (ALT) levels, and liver histology. · bmj.com

We could not place any of them by their address. None is an official body: that part stands on reporting, not on the underlying document or transcript.